Biomarkers for the Progression of Intermediate Age-Related Macular Degeneration

Biomarkers for the Progression of Intermediate Age-Related Macular Degeneration

Abstract Age-related macular degeneration (AMD) is a leading cause of severe vision loss worldwide, with a global prevalence that is predicted to substantially increase. Identifying early biomarkers indicative of progression risk will improve our ability to assess which patients are at greatest risk...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs:	Eleonora M. Lad, Robert P. Finger, Robyn Guymer
Formaat:	Artikel
Taal:	English
Gepubliceerd in:	Adis, Springer Healthcare 2023-09-01
Reeks:	Ophthalmology and Therapy
Onderwerpen:	Age-related macular degeneration Biomarkers iAMD Geographic atrophy Neovascular AMD
Online toegang:	https://doi.org/10.1007/s40123-023-00807-9

Gelijkaardige items

Patterns of Gene Expression, Splicing, and Allele-Specific Expression Vary among Macular Tissues and Clinical Stages of Age-Related Macular Degeneration
door: Treefa Shwani, et al.
Gepubliceerd in: (2023-11-01)

Age-Related Macular Degeneration: Classification and Pathogenesis
door: İmren Akkoyun
Gepubliceerd in: (2014-12-01)

Current and Novel Therapeutic Approaches for Treatment of Neovascular Age-Related Macular Degeneration
door: Reem H. ElSheikh, et al.
Gepubliceerd in: (2022-11-01)

Serum lipids in adults with late age-related macular degeneration: a case-control study
door: Richard D. Semba, et al.
Gepubliceerd in: (2019-01-01)

Off-Label Use of Bevacizumab in Patients Diagnosed with Age-Related Macular Degeneration: A Systematic Review and Meta-Analysis
door: João Estarreja, et al.
Gepubliceerd in: (2024-07-01)

Genetics and Age-Related Macular Degeneration: A Practical Review for Clinicians
door: Julia Nguyen, et al.
Gepubliceerd in: (2024-02-01)

Potential Therapeutic Candidates for Age-Related Macular Degeneration (AMD)
door: Sonali Nashine
Gepubliceerd in: (2021-09-01)

Age-Related Macular Degeneration: Therapeutic Strategies and Future Approaches
door: Răzvan Vasile ROPCIUC
Gepubliceerd in: (2024-05-01)

A comprehensive review on early detection of drusen patterns in age-related macular degeneration using deep learning models
door: Kiruthika M, et al.
Gepubliceerd in: (2025-02-01)

Global Insights from Patients, Providers, and Staff on Challenges and Solutions in Managing Neovascular Age-Related Macular Degeneration
door: Anat Loewenstein, et al.
Gepubliceerd in: (2024-12-01)

Role of Complement in the Onset of Age-Related Macular Degeneration
door: Niloofar Piri, et al.
Gepubliceerd in: (2023-05-01)

The Role of Inflammation in Age-Related Macular Degeneration—Therapeutic Landscapes in Geographic Atrophy
door: Grace A. Borchert, et al.
Gepubliceerd in: (2023-08-01)

Etiopathogenesis of non-exudative age-related macular degeneration (literature review)
door: M. M. Bikbov, et al.
Gepubliceerd in: (2022-03-01)

Plasma Metabolites Associated with OCT Features of Age-Related Macular Degeneration
door: Ines Lains, MD, PhD, et al.
Gepubliceerd in: (2024-01-01)

Cost-effectiveness analysis of brolucizumab versus aflibercept for the treatment of neovascular age-related macular degeneration (nAMD) in Italy
door: Nicola Ferrante, et al.
Gepubliceerd in: (2022-04-01)

Early and intermediate age-related macular degeneration: update and clinical review
door: García-Layana A, et al.
Gepubliceerd in: (2017-10-01)

Prevalence of insomnia and depression in patients with age-related macular degeneration
door: Elżbieta Nowak, et al.
Gepubliceerd in: (2018-07-01)

Intravitreal Brolucizumab in Patients with Aflibercept-Resistant Neovascular Age-Related Macular Degeneration
door: Ashwin Gupta, et al.
Gepubliceerd in: (2022-01-01)

Eye Drop with Fas-Blocking Peptide Attenuates Age-Related Macular Degeneration
door: Yujong Yi, et al.
Gepubliceerd in: (2024-03-01)

Plasma Metabolomics of Intermediate and Neovascular Age-Related Macular Degeneration Patients
door: Sabrina L. Mitchell, et al.
Gepubliceerd in: (2021-11-01)

Dry and neovascular “wet” age-related macular degeneration: Upcoming therapies
door: Audrey Yan, et al.
Gepubliceerd in: (2025-01-01)

Linking Adiponectin and Its Receptors to Age-Related Macular Degeneration (AMD)
door: Mayank Choubey, et al.
Gepubliceerd in: (2023-11-01)

Efficacy and safety of brolucizumab versus aflibercept in patients with neovascular age-related macular degeneration: a randomized trial in Indian patients
door: Sanjay Kumar Mishra, et al.
Gepubliceerd in: (2022-07-01)

Antioxidants in Age-Related Macular Degeneration: Lights and Shadows
door: Uday Pratap Singh Parmar, et al.
Gepubliceerd in: (2025-01-01)

Genetic Insights into Age-Related Macular Degeneration
door: Bhumika, et al.
Gepubliceerd in: (2024-07-01)

Safety and efficacy of Razumab™ (world’s first biosimilar ranibizumab) in wet age-related macular degeneration: a post-marketing, prospective ASSET study
door: Shashikant Sharma, et al.
Gepubliceerd in: (2021-03-01)

Retinal Progression Biomarkers of Early and Intermediate Age-Related Macular Degeneration
door: Rita Flores, et al.
Gepubliceerd in: (2021-12-01)

Berries and Their Active Compounds in Prevention of Age-Related Macular Degeneration
door: Xiang Li, et al.
Gepubliceerd in: (2024-12-01)

Dietary and Lifestyle Factors Modulate the Activity of the Endogenous Antioxidant System in Patients with Age-Related Macular Degeneration: Correlations with Disease Severity
door: Zofia Ulańczyk, et al.
Gepubliceerd in: (2020-10-01)

Oxidative Stress, Persistent Inflammation and Blood Coagulation Alterations in Serum Proteome of Patients with Neovascular Age-Related Macular Degeneration
door: Mateusz Winiarczyk, et al.
Gepubliceerd in: (2024-05-01)

Novel Epigenetic Clock Biomarkers of Age-Related Macular Degeneration
door: Saurav Mallik, et al.
Gepubliceerd in: (2022-06-01)

Deep Learning Approach for Age-related Macular Degeneration Detection Using Retinal Images: Efficacy Evaluation of Different Deep Learning Models
door: Ngoc Thien Le, et al.
Gepubliceerd in: (2023-12-01)

Efficacy and Safety of Nutraceutical Support in Age-Related Macular Degeneration Patients
door: S. V. Yanchenko, et al.
Gepubliceerd in: (2023-01-01)

A prospective, randomized, parallel group, double blind, multicenter study to compare the efficacy, safety and immunogenicity of Lupin's Ranibizumab with Lucentis® in patients with neovascular age-related macular degeneration
door: Ramandeep Singh, et al.
Gepubliceerd in: (2022-01-01)

Treatment Strategies for Anti-VEGF Resistance in Neovascular Age-Related Macular Degeneration by Targeting Arteriolar Choroidal Neovascularization
door: Yingbin Fu, et al.
Gepubliceerd in: (2024-02-01)

Case Series on Initial Responses to Intravitreal Brolucizumab in Patients with Recalcitrant Chronic Wet Age-Related Macular Degeneration
door: Avaylon J, et al.
Gepubliceerd in: (2020-05-01)

Geographic Atrophy after Reabsorption of Pigment Epithelial Detachment (GARPED) study
door: Enoch T. Peng, et al.
Gepubliceerd in: (2023-05-01)

Exploring the role of granzyme B in subretinal fibrosis of age-related macular degeneration
door: Karanvir Gill, et al.
Gepubliceerd in: (2024-07-01)

Anatomical and functional responses to single brolucizumab injection in neovascular age-related macular degeneration patients not responding to antiangiogenics: a case series
door: Silvio Zuccarini, et al.
Gepubliceerd in: (2022-03-01)

Genetic Association between MMP9 and Choroidal Neovascularization in Age-Related Macular Degeneration
door: Elliott H. Sohn, MD, et al.
Gepubliceerd in: (2021-03-01)